Skip to main content

99%+ HPLC Pure | Batch-Specific Third-Party COAs | Free Shipping Over $250

Menu

Kynetide Research Team | 3 days ago

Rice Engineers Find a Way to Make Peptides Stay Put Longer in Gelatin Delivery Systems

Peptides are prized for their ability to drive specific biological processes like bone formation and tissue repair, but their small size has always worked against them in drug delivery: once placed in water-rich materials like hydrogels, they tend to diffuse away long before healing is complete. A new Rice University study, published in Cell Biomaterials, offers a surprisingly simple fix.

The Problem, The Fix, and Why It Matters

The Problem: Led by bioengineer Antonios Mikos in collaboration with researchers at Kyoto University, the team focused on osteogenic growth peptide (OGP), a small molecule studied for its role in bone formation. Peptides like OGP are stable and easy to manufacture compared to larger proteins, but their size makes them hard to keep at a treatment site for the days or weeks that healing typically requires.


The Fix: The researchers added short sequences of charged amino acids to OGP, creating positively charged, negatively charged, and electrically neutral versions, then loaded each into gelatin microparticles. Gelatin was chosen because it's biocompatible, already common in regenerative medicine, and naturally carries a charge that varies depending on how it's processed. The team found that when the peptide and the gelatin carried opposite charges, the resulting electrostatic attraction, similar to opposite poles of a magnet, could stretch the peptide's release out to two or three weeks, far longer than untreated versions. As Mikos put it, modifying a peptide's charge can "substantially extend its release."


Why It Matters: Positively charged peptide modifications in particular improved retention and reduced the "burst release" that often undermines drug-delivery materials as soon as they're placed in a liquid environment. For a field increasingly focused on turning peptides into practical therapeutics, formulation tricks like this may end up mattering as much as the peptides themselves.


Source: News-Medical / Rice University, Aug 7, 2026

Let’s create what matters — together.

Kynetide Research Team

More Posts

New Real-World Study Links Tirzepatide to Fewer Heart Attacks in Type 2 DiabetesNew Real-World Study Links Tirzepatide to Fewer Heart Attacks in Type 2 Diabetes
New Real-World Study Links Tirzepatide to Fewer Heart Attacks in Type 2 Diabetes

Tirzepatide is best known for its glucose- and weight-lowering effects, but a newly published study adds evidence for another benefit: a real reduction in serious cardiovascular events. Published in The British Medical Journal, it's one of the largest real-world looks yet at how tirzepatide performs on cardiovascular outcomes outside a clinical trial setting.

Aug 10 | Kynetide Research Team
A Harvard Medical Perspective on the Peptide BoomA Harvard Medical Perspective on the Peptide Boom
A Harvard Medical Perspective on the Peptide Boom

Harvard Health Publishing recently examined the fast-growing world of injectable peptides, from FDA-approved medications like insulin and GLP-1 drugs to the unregulated compounds sold online for research and personal use. Their findings offer a useful checkpoint for anyone following the peptide space, including everyone in our own research community.

Aug 7 | Kynetide Research Team
A New Accreditation Body Wants to Standardize Peptide Quality — Here's What It Means for ResearchersA New Accreditation Body Wants to Standardize Peptide Quality — Here's What It Means for Researchers
A New Accreditation Body Wants to Standardize Peptide Quality — Here's What It Means for Researchers

A new nonprofit is building the first peptide-specific accreditation standards for compounding and sourcing, just as regulators weigh whether to expand access to several popular research peptides.

Aug 5 | Kynetide Research Team
Inside the Peptide Controversy: Why FDA Scientists and Critics Are Pushing BackInside the Peptide Controversy: Why FDA Scientists and Critics Are Pushing Back
Inside the Peptide Controversy: Why FDA Scientists and Critics Are Pushing Back

The FDA advisory panel's vote to ease restrictions on six peptides made headlines this week. But the vote wasn't as clear-cut as the headlines suggest. Behind the scenes, FDA's own scientific staff recommended against it, several panel members have documented industry ties, and the peptides in question are already circulating on the unregulated gray market. Here's what the coverage is missing.

Aug 5 | Kynetide Research Team
Peptides Still Aren't Legal: What the FDA Advisory Panel Vote Actually MeansPeptides Still Aren't Legal: What the FDA Advisory Panel Vote Actually Means
Peptides Still Aren't Legal: What the FDA Advisory Panel Vote Actually Means

Last month's FDA advisory panel vote on peptide compounding made headlines everywhere — but it's created almost as much confusion as clarity. Here's what actually changed, what hasn't, and what to expect next.

Aug 4 | Kynetide Research Team
5 Red Flags to Watch For When Choosing a Research Peptide Supplier5 Red Flags to Watch For When Choosing a Research Peptide Supplier
5 Red Flags to Watch For When Choosing a Research Peptide Supplier

With regulatory attention on peptide purity and sourcing higher than ever, knowing how to evaluate a supplier yourself is one of the most useful skills a researcher can have. Here are five warning signs that should make you think twice before ordering.

Aug 4 | Kynetide Research Team
FDA Advisory Panel Backs Six Peptides for Compounding: What It Means for the Research MarketFDA Advisory Panel Backs Six Peptides for Compounding: What It Means for the Research Market
FDA Advisory Panel Backs Six Peptides for Compounding: What It Means for the Research Market

A look at the FDA's July 2026 compounding-committee vote on six popular peptides, the safety concerns it has raised among the agency's own scientists and patient-safety groups, and why verified, lab-tested sourcing still matters most.

Aug 3 | Kynetide Research Team
Peptide Stacking 101: Combining Research Peptides SafelyPeptide Stacking 101: Combining Research Peptides Safely
Peptide Stacking 101: Combining Research Peptides Safely

Many research protocols call for combining more than one peptide at a time, but stacking introduces its own set of variables beyond what a single-compound study requires. This guide covers the basics of peptide stacking: why researchers combine compounds, how to think about complementary mechanisms, timing and injection site considerations when multiple peptides are in use, and the documentation habits that keep a multi-compound protocol interpretable.

Aug 2 | Jane Smith
Peptide Injection Technique 101: Sites, Needles, and TechniquePeptide Injection Technique 101: Sites, Needles, and Technique
Peptide Injection Technique 101: Sites, Needles, and Technique

Reconstituting and dosing a peptide correctly only gets a researcher halfway there — the injection itself matters just as much. This guide covers subcutaneous injection basics for research peptides: choosing an appropriate site, needle gauge and length considerations, site rotation to avoid tissue irritation, and the common technique mistakes that can affect a study's consistency.

Aug 1 | Jane Smith